Search results for "allergic"

showing 10 items of 307 documents

The effect of residential urban greenness on allergic respiratory diseases in youth: A narrative review

2020

Abstract Background Environmental exposures across the life course may be a contributor to the increased worldwide prevalence of respiratory and allergic diseases occurring in the last decades. Asthma and rhinoconjunctivitis especially contribute to the global burden of disease. Greenness has been suggested to have beneficial effects in terms of reduction of occurrence of allergic respiratory diseases. However, the available evidence of a relationship between urban greenness and childhood health outcomes is not yet conclusive. The current review aimed at investigating the current state of evidence, exploring the relationship between children's exposure to residential urban greenness and dev…

lcsh:Immunologic diseases. AllergyPulmonary and Respiratory Medicineallergic respiratory diseasesgreennessImmunologyPopulationMEDLINEreviewArticleAllergic sensitization03 medical and health sciences0302 clinical medicineEnvironmental health11. SustainabilityImmunology and AllergyMedicine030223 otorhinolaryngologyeducationExposure assessmentAsthmayoutheducation.field_of_studybusiness.industryrhinoconjunctivitislung functionasthmamedicine.disease3. Good healthgreenness asthma rhinoconjunctivitis lung function youth030228 respiratory systemBronchitisLife course approachNarrative reviewlcsh:RC581-607business
researchProduct

Is cytokine expression responsible for differences between allergens and irritants?

1996

Abstract Irritant and allergic contact dermatitis are two very similar diseases, and differentiating between these two can be difficult clinically. Recently, cytokines have been identified as useful tools for differentiation. Thus, our laboratory has identified an early cytokine pattern in the induction phase of contact sensitivity that is specific for allergens and is not found after epicutaneous application of irritants or tolerogens. The upregulation of the Langerhans' cell—derived signal interleukin (IL)-1β early after allergen application especially seems to be highly specific for contact allergens. This cytokine was also found to be essential for the development of epicutaneous sensit…

medicine.drug_classChemistrymedicine.medical_treatmentInterleukinDermatologyAllergensMonoclonal antibodymedicine.disease_causemedicine.diseaseDermatitis ContactProinflammatory cytokineInterleukin-10CytokineAllergenmedicine.anatomical_structureDownregulation and upregulationImmunologyDermatitis Allergic ContactmedicineIrritantsCytokinesHumansAllergic contact dermatitisSensitizationInterleukin-1American journal of contact dermatitis : official journal of the American Contact Dermatitis Society
researchProduct

Comment on “Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab”

2020

medicine.medical_specialty2019-20 coronavirus outbreakUrticariaCoronavirus disease 2019 (COVID-19)ExacerbationSARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Symptom Flare UpTreatment outcomeMEDLINECOVID-19OmalizumabDermatologyOmalizumabInternal medicineAnti-Allergic AgentsCorrespondenceHumansMedicineChronic Urticariabusinessmedicine.drugInternational Journal of Dermatology
researchProduct

Late allergic reaction following sialography

2002

medicine.medical_specialtyAllergic reactionOtorhinolaryngologymedicine.diagnostic_testbusiness.industrymedicineRadiology Nuclear Medicine and imagingGeneral MedicineSialographynessunabusinessGeneral DentistryDermatology
researchProduct

Cutaneous and Allergic reactions due to COVID‐19 vaccinations: A review

2021

ABSTRACT Introduction The pandemic caused by the novel coronavirus disease 2019 (COVID‐19) has had an unprecedented impact on the overall health and the global economy. Vaccination is currently the most dependable strategy to end the pandemic, despite the slower‐than‐hoped‐for rollout, particularly for low‐to‐middle‐income countries, and the uncertain duration of protection afforded by vaccination. The spike protein of the virus (immunodominant antigen of the virus) is the main target of the approved and candidate SARS‐CoV‐2 vaccines. This protein binds to the ACE2 receptor of the host cell, initiating the entry of the virus into the cell and the chain of subsequent events ending to Acute R…

medicine.medical_specialtyAllergyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)ExacerbationReview ArticleDermatologyallergic reactionsmedicine.disease_causeSARS‐CoV‐2VirusAntigenCOVID‐19PandemicHypersensitivityHumansMedicineIntensive care medicineReview ArticlesCoronavirusbusiness.industryVaccinationCOVID-19cutaneous reactionsmedicine.diseaseVaccinationBNT162b2mRNA VaccinesbusinessJournal of Cosmetic Dermatology
researchProduct

The spectrum of allergic (cross-)sensitivity in clinical patch testing with 'para amino' compounds

2002

Background: Allergic contact sensitization to ‘para amino’ compounds is frequent and the spectrum of cross-reactivity between members of this chemical group is variable. Methods: A retrospective analysis of clinical patch test data obtained with a special test series in the centres of the Information Network of Departments of Dermatology (IVDK) between 1995 and 1999. Results: In the 638 patients tested with the above test panel positive reactions were observed most often to p-aminoazobenzene (16.2%), p-phenylenediamine (14.1%), p-toluylenediamine (10.0%), followed by 4,4′-diaminodiphenylmethane (8.5%), Disperse Orange 3 (8.4%) and p-aminophenol (3.1%). Among the 544 patients tested with p-p…

medicine.medical_specialtyAllergyConcordanceCross sensitivityStatistics as TopicImmunologyCross ReactionsPhenylenediaminesAminophenolsmedicine.disease_causeCross-reactivity030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compoundSulfanilamide0302 clinical medicineGermanySulfanilamidesmedicineHumansImmunology and AllergyAminesRetrospective Studiesbusiness.industryPatch testp-PhenylenediamineAllergensPatch Testsmedicine.diseaseDermatology3. Good healthchemistryP-Aminoazobenzenep-Aminoazobenzene030220 oncology & carcinogenesisDermatitis Allergic ContactImmunologybusiness4-Aminobenzoic AcidContact dermatitisAllergy
researchProduct

Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A systematic review and meta-analysis

2010

Background The benefit of sublingual immunotherapy (SLIT) with grass allergens for seasonal allergic rhinitis has been extensively studied, but data on efficacy are still equivocal. Objective To assess the effectiveness of SLIT with grass allergens in the reduction of symptoms and medication in patients with seasonal allergic rhinitis to grass pollen. Methods Computerized bibliographic searches of MEDLINE (1995-2010) were supplemented by hand searches of reference lists. Studies were included if they were double-blind randomized controlled trials (RCTs) comparing SLIT to placebo and if they included patients with history of allergy to grass pollen treated with natural grass pollen extracts.…

medicine.medical_specialtyAllergyMEDLINEImmunologyAdministration SublingualPlaceboPoaceaelaw.inventionSublingual administrationRandomized controlled triallawInternal medicineotorhinolaryngologic diseasesImmunology and AllergyMedicineHumansSublingual immunotherapy rhinitis grass meta-analysisAdverse effectRandomized Controlled Trials as Topicbusiness.industryfood and beveragesRhinitis Allergic Seasonalmedicine.diseaseSlitTreatment OutcomeStrictly standardized mean differenceMeta-analysisImmunologyPollenImmunotherapybusiness
researchProduct

Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management…

2020

Background Experience in Helicobacter pylori eradication treatment of patients allergic to penicillin is very scarce. A triple combination with a PPI, clarithromycin (C), and metronidazole (M) is often prescribed as the first option, although more recently the use of a quadruple therapy with PPI, bismuth (B), tetracycline (T), and M has been recommended. Aim To evaluate the efficacy and safety of first-line and rescue treatments in patients allergic to penicillin in the "European Registry of H pylori management" (Hp-EuReg). Methods A systematic prospective registry of the clinical practice of European gastroenterologists (27 countries, 300 investigators) on the management of H pylori infect…

medicine.medical_specialtyAllergySettore MED/12 - GASTROENTEROLOGIAallergicPenicillinsGastroenterologyHelicobacter InfectionsDrug Hypersensitivity03 medical and health sciences0302 clinical medicineLevofloxacinMetronidazoleClarithromycinInternal medicinebismuthmedicineHumansProspective StudiesRegistriesAdverse effectlevofloxacinbiologyHelicobacter pyloribusiness.industrySettore MED/09 - MEDICINA INTERNAallergic ; allergy ; bismuth ; clarithromycin ; Helicobacter pylori ; levofloxacin ; penicillinGastroenterologyProton Pump InhibitorsGeneral MedicineTetracyclineHelicobacter pyloribiology.organism_classificationmedicine.diseaseallergyclarithromycinAnti-Bacterial Agents3. Good healthPenicillinMetronidazoleRegimenInfectious Diseasespenicillin030220 oncology & carcinogenesisDrug Therapy Combination030211 gastroenterology & hepatologybusinessmedicine.drug
researchProduct

Patch testing in children--recommendations of the German Contact Dermatitis Research Group (DKG).

2007

Summary Allergic contact dermatitis occurs frequently in children. Patch testing is needed to identify the responsible allergens and should be performed in children. We recommend a panel of 12 contact allergens as a standard series in children from 6–12 years. Four additional contact allergens should be tested in case of a positive history or suggestive clinical picture. For patch testing in children, the allergens should be applied for 24 hours and the readings should be performed at 48 and 72 hours. Standardized patch testing makes it possible to systematically investigate allergic contact dermatitis and identify relevant allergens in children.

medicine.medical_specialtyDermatitisDermatologyPediatricsPatch testing030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineimmune system diseases030225 pediatricsGermanyotorhinolaryngologic diseasesmedicineHumansContact allergensPractice Patterns Physicians'Allergic contact dermatitisbusiness.industryrespiratory systemPatch Testsmedicine.diseaseDermatologyrespiratory tract diseases3. Good healthDermatitis Allergic ContactPractice Guidelines as TopicbusinessContact dermatitisJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
researchProduct

Review of biologics in allergic contact dermatitis

2020

The resistant and recalcitrant nature of severe allergic contact dermatitis (ACD) makes its management challenging. With advances in the understanding of the cellular and molecular pathogenesis of ACD, newer therapeutic targets are becoming apparent. In particular, the use of biologics has gained momentum, given the specificity of their action. This article aims to review the presently available data on the use of biologics in ACD. English-language-based literature available on the use of biological therapy was thoroughly probed in the following databases as on October 14, 2019: PubMed, Google Scholar, The Cochrane library, Embase, Scopus, and EBSCO. The following keywords were used: "conta…

medicine.medical_specialtyDermatologyOmalizumabEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineUstekinumabmedicineAdalimumabHumansImmunology and Allergy030212 general & internal medicineAllergic contact dermatitisBiological Productsbusiness.industryPatch Testsmedicine.diseaseDermatologyDupilumabInfliximabTreatment OutcomeDermatitis Allergic ContactSecukinumabbusinessmedicine.drugContact Dermatitis
researchProduct